These processes collectively contribute to IR and, ultimately, T2DM [70]
Compounding may be appropriate when: A required dose, concentration, or formulation is not commercially available An FDA-approved drug is in a temporary shortage A patient has a documented allergy or intolerance to an inactive ingredient Compounding is intended to address medical necessity , not convenience, mass substitution, or price alone
Future clinical studies should determine which patient groups should be targeted as potential candidates for the symptomatic and/or neuroprotective effects of GLP-1RAs, to find out, whether combinations of GLP-1RA with other classes of drugs can further enhance their effectiveness, and evaluate their long-term effect on the course of the disease and side effects
Pre-filled pens like the Ozempic pen and Mounjaro pen handle dose dialing, needle attachment, and injection mechanics in a single integrated device
Would you project that's going to be possible in the years ahead
March 18, 2021